Review highlights BDNF/TrkB signaling mechanisms in kidney diseases, suggesting new therapeutic targets for renal protection.
Brain-derived neurotrophic factor (BDNF) is a key member of the neurotrophin family that promotes neuronal function via its receptor kinase TrkB. However, recent work has demonstrated BDNF as a multifaceted regulator beyond its classic roles in the nervous system, particularly in renal patho-physiology. This review summarizes the recent advances about BDNF/TrkB signaling pathway in various kidney diseases, including chronic kidney disease (CKD) and acute kidney injury (AKI). Upon binding TrkB, BDNF initiates specific intracellular signaling pathways, such as PI3K-Akt, MAPK-ERK, and PLCγ, to support cell survival, mitochondrial function, cytoskeletal integrity, and anti-inflammatory responses. As such, the BDNF-TrkB pathway represents a potential target for renal protection and regeneration, warranting further mechanistic and clinical investigation.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: